C.L. King analyst Kristen Stewart maintains $Teleflex (TFX.US)$ with a buy rating, and adjusts the target price from $293 to $274.
According to TipRanks data, the analyst has a success rate of 60.2% and a total average return of 3.6% over the past year.
Furthermore, according to the comprehensive report, the opinions of $Teleflex (TFX.US)$'s main analysts recently are as follows:
Teleflex's third-quarter revenue shortfall was attributed to an unexpected loss of an OEM customer and a decrease in UroLift's performance. Nonetheless, it is believed that the underlying business fundamentals of Teleflex remain solid and that the company is progressing towards its margin expansion goals.
The assessment of Teleflex's third-quarter report was characterized as 'mixed,' with expectations that near-term conditions may continue to be challenging. Nonetheless, the outlook for the Urology segment, bolstered by the momentum of Pallette, appears positive.
Note:
TipRanks, an independent third party, provides analysis data from financial analysts and calculates the Average Returns and Success Rates of the analysts' recommendations. The information presented is not an investment recommendation and is intended for informational purposes only.
Success rate is the number of the analyst's successful ratings, divided by his/her total number of ratings over the past year. A successful rating is one based on if TipRanks' virtual portfolio earned a positive return from the stock. Total average return is the average rate of return that the TipRanks' virtual portfolio has earned over the past year. These portfolios are established based on the analyst's preliminary rating and are adjusted according to the changes in the rating.
TipRanks provides a ranking of each analyst up to 5 stars, which is representative of all recommendations from the analyst. An analyst's past performance is evaluated on a scale of 1 to 5 stars, with more stars indicating better performance. The star level is determined by his/her total success rate and average return.